Compound Profile Scientific & Efficacy Data C 400 H 625 N 111 O 115 S 9 Molecular Formula 9111.4 g/mol Molecular Weight 20-30 hours Half-Life High when injected subcutaneously or intramuscularly Bioavailability 946870-92-4 CAS # Not assigned PubChem Status Developed By 1987 Francis John Ballard and colleagues CSIRO Division of Human Nutrition, Adelaide, Australia Primary Benefits One of the most potent peptides for muscle building through both hypertrophy and hyperplasia mechanisms Significantly accelerates post-workout recovery and tissue repair, allowing more frequent intense training Enhances how efficiently your body uses protein and carbohydrates for muscle building versus fat storage Amino Acid Sequence MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA (83 amino acids with Arg3 substitution and 13 amino acid N-terminal extension) Dosing How much do I take
C., Martins, S
Understanding the evidence helps you make an informed choice about when to start GLP-1 therapy and how to prioritize both your health and your nursing infant's safety
Tirzepatide affects appetite, blood sugar regulation, and digestion, which can help address metabolic changes that occur during perimenopause and menopause
2 024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 36673672 (IEEE, Lisbon, Portugal, 2024)
Other candidates continue to advance, reflecting how active obesity drug development has become
